Table 2.
Baseline characteristics of studied population B
| Characteristics | Low TT level (n = 53) | Normal TT (n = 214) | p value |
|---|---|---|---|
| Age, years | 34.30±0.92 | 33.19±0.43 | 0.253 |
| BMI, kg/m2 | 27.74±0.50 | 25.29±0.23 | <0.001 |
| WC, cm | 97.13±1.27 | 89.46±0.67 | <0.001 |
| HSI | 37.89±0.68 | 34.68±0.36 | <0.001 |
| LAP | 82.96±8.81 | 43.89±2.82 | <0.001 |
| FLI | 64.94±3.32 | 42.17±1.87 | <0.001 |
| TC, mmol/L | 5.16±0.10 | 4.99±0.06 | 0.167 |
| TG, mmol/L | 2.56±0.25 | 1.70±0.09 | 0.002 |
| LDL-C, mmol/L | 3.22±0.08 | 3.13±0.04 | 0.337 |
| HDL-C, mmol/L | 1.11±0.03 | 1.17±0.02 | 0.073 |
| ALT, U/L | 36.64±3.48 | 32.20±1.48 | 0.201 |
| AST, U/L | 28.68±2.68 | 26.16±0.74 | 0.208 |
| GGT, U/L | 45.40±5.08 | 36.34±1.78 | 0.040 |
| ALP, U/L | 99.15±3.18 | 92.12±1.40 | 0.031 |
| URIC, μmol/L | 386.87±11.30 | 385.32±5.24 | 0.896 |
| INS, μIU/mL | 15.67±0.96 | 10.97±0.38 | <0.001 |
| FPG, mmol/L | 5.45±0.09 | 5.48±0.09 | 0.909 |
| HbA1C, % | 5.37±0.06 | 5.43±0.09 | 0.756 |
| HOMA-IR | 3.89±0.30 | 2.69±0.10 | <0.001 |
| FSH, mIU/mL | 5.19±0.36 | 4.84±0.15 | 0.325 |
| LH, mIU/mL | 4.54±0.29 | 5.14±0.13 | 0.050 |
| E2, pg/mL | 28.61±1.13 | 31.75±0.69 | 0.037 |
| TT, ng/dL | 323.75±6.83 | 570.36±11.72 | <0.001 |
| SHBG, nmol/L | 22.47±0.85 | 37.26±1.13 | <0.001 |
| FTI, % | 53.02±1.97 | 57.13±1.14 | 0.101 |
Continuous variables are presented as mean ± standard error of the mean.
TT, total testosterone; BMI, body mass index; WC, waist circumference; HSI, hepatic steatosis index; LAP, lipid accumulation product; FLI, fatty liver index; TC, total cholesterol; TG, triglyceride; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; INS, insulin; FPG, fasting plasma glucose; HbA1c, glycosylated hemoglobin; HOMA-IR, homeostasis model assessment of insulin resistance; FSH, follicle-stimulating hormone; LH, luteinizing hormone; E2, estradiol; SHBG, sex hormone-binding globulin; FTI, free testosterone index.